Benitec Biopharma Inc. - 8-K Filing
Benitec Biopharma reports Q1 FY2027 net loss of $12.9 million and announces transition to a calendar year fiscal cycle. (Items: 2.02 Results of Operations and Financial Condition, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 9.01 Financial Statements and Exhibits)
Tickers: $BNTC